Full Coverage

AVEO Pharmaceuticals Granted Patent for Unique Genetic Screen to Identify Novel Cancer Drug...

                   
yahoo.com
May 22, 2008
        
Story Timeline:  196 days

CAMBRIDGE, Mass.----AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. [read full story]                    

Add Comment
Latest article on this story:

AVEO Pharmaceuticals Granted Patent for Unique Genetic Screen to Identify Novel Cancer Drug Targets

 redorbit.com May 22, 2008
First article on this story:

AVEO Pharmaceuticals Granted Patent for Unique Genetic Screen to Identify Novel Cancer Drug Targets

 pharmiweb.co.uk May 22, 2008
Selected publications with coverage of this story:
redorbit.com yahoo.com pharmiweb.co.uk
RELATED
Found 1 documents:
                   

AVEO Pharmaceuticals Granted Patent for Unique Genetic Screen to Identify Novel Cancer Drug Targets

redorbit.com
May 22, 2008
        

AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that on May 13, 2008, the United States Patent and Trademark Office granted U.S. Patent No.